Mastro-Martínez, IgnacioPérez-Ortega, María JUrrutia, EmiliaOrtega-Acosta, María JPacheco Sánchez-Lafuente, Francisco J2023-01-252023-01-252019http://hdl.handle.net/10668/13703Congenital neuroblastoma is the most frequent malignant solid tumor in the neonatal period. The clinical presentation is usually either by prenatal diagnosis or by palpation of an abdominal mass. Staging allows classifying it according to risk groups with a different prognosis and treatment. In the neonatal period, it is characterized by a high rate of spontaneous regression and good prognosis (disease-free survival at 5 years greater than 90 %). We present a clinical case of congenital neuroblastoma whose presentation, shock and hypertension, was only described on a previous occasion. Antihypertensive treatment along with systemic chemotherapy produced clinical control and patient improvement.esCongenital neuroblastomaHypertensionNeonatologyShockAcute DiseaseAntihypertensive AgentsAntineoplastic AgentsHumansHypertensionInfant, NewbornMaleNeuroblastomaShockresearch article30869498open access10.5546/aap.2019.e1631668-3501https://doi.org/10.5546/aap.2019.e163